ニューヨークにおける骨髄異形成症候群の臨床試験
ニューヨーク内の拠点で、骨髄異形成症候群に関する38件の研究が参加者を募集しています。
ニューヨーク内の都市
- New York City21件の研究
- The Bronx9件の研究
- Buffalo8件の研究
- Rochester6件の研究
- Queens6件の研究
- Greenburgh5件の研究
- New Rochelle3件の研究
- Staten Island3件の研究
公式研究テキスト（英語）
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- Roswell Park Cancer Institute, Buffalo
- Stony Brook University Medical Center, Stony Brook
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06577441Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06484062A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
12歳〜78歳 · 全性別 · 2026/09/29更新 · NCT03802695MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- Northwell Health/Center for Advanced Medicine, Lake Success
- 他9件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05564390Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT05320198A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Hematology Oncology Associates of Rockland, Nyack
- Albert Einstein College - Montefiore, The Bronx
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07422480Collection of Tissue Samples for Cancer Research
- Roswell Park Cancer Institute, Buffalo
被験者募集中観察研究
2 Months · 全性別 · 2026/09/16更新 · NCT00900198A Telehealth Advance Care Planning Intervention
- University of Rochester, Rochester
被験者募集中
60歳以上 · 全性別 · 2026/09/11更新 · NCT05875805Cord Blood Transplant in Adults With Blood Cancers
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第2相
21歳〜65歳 · 全性別 · 2026/09/11更新 · NCT05884333Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
- MSKCC, New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06465953The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- NYU Langone Hospital - Long Island, Mineola
- 他7件
被験者募集中第1/2相
22歳以下 · 全性別 · 2026/08/25更新 · NCT04726241A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Northwell Health, Lake Success
- Clinical Research Alliance NY, Westbury
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06499285A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- New York Cancer and Blood, Shirley
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/21更新 · NCT04419649ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- NYU Langone Health, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT06656494Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
- Ichan School of Medicine at Mount Sinai, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/10更新 · NCT05308264Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Research Site, New York
被験者募集中第1/2相
16歳以上 · 全性別 · 2026/07/20更新 · NCT07155226Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
- Albany Medical Center, Albany
被験者募集中観察研究
30歳以下 · 全性別 · 2026/07/16更新 · NCT04968834Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07216443Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
- Wilmot Cancer Institute, University of Rochester, Rochester
被験者募集中早期第1相
18歳〜75歳 · 全性別 · 2026/06/03更新 · NCT03964506Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
被験者募集中第2相
26歳以下 · 全性別 · 2026/05/14更新 · NCT07566377A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Roswell Park Comprehensive Cancer Center, Buffalo
- New York University Langone Hospital - Long Island, Mineola
- Perlmutter Cancer Center - 34th Street, New York
- 他2件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/04/30更新 · NCT04256317A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
- Icahn School of Medicine at Mount Sinai, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06146257A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
- The University of Rochester, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT05732103Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/25更新 · NCT07107126A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Roswell Park Comprehensive Cancer Center, Buffalo
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/03/24更新 · NCT04988555FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
- Montefiore Medical Center, The Bronx
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/03更新 · NCT07283094CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Roswell Park Cancer Institute, Buffalo
- New York University, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/01/16更新 · NCT05143996Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
- Montefiore Einstein Cancer Center and Children's Hospital at Montefiore (CHAM), The Bronx
被験者募集中第1相
18歳〜75歳 · 全性別 · 2026/01/08更新 · NCT05342584Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- Montefiore Medical Center, The Bronx
- White Plains Hospital, White Plains
被験者募集中第2相
18歳以上 · 全性別 · 2026/01/05更新 · NCT05184842Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- Montefiore Medical Center, The Bronx
被験者募集中第1相
18歳以上 · 全性別 · 2025/12/23更新 · NCT04245397Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
- Montefiore Medical Center, The Bronx
被験者募集中第1相健康なボランティア歓迎
18歳以上 · 全性別 · 2025/11/10更新 · NCT05986240SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- 他2件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Umbilical Cord Blood Transplantation From Unrelated Donors
- Wilmot Cancer Institute, Rochester
被験者募集中観察研究
2 Months – 75 Years · 全性別 · 2025/10/10更新 · NCT03016806A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2025/09/24更新 · NCT06501196Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
- University of Rochester Medical Center, Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2025/09/17更新 · NCT01311258Study of REM-422 in Patients With AML or Higher Risk MDS
- Memorial Sloan Kettering, New York
被験者募集中第1相
18歳以上 · 全性別 · 2025/04/23更新 · NCT06297941Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2025/04/15更新 · NCT06462365A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Memorial Sloan-Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2024/03/20更新 · NCT04243785ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。